Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
3 May 24
ARS
2023 FY
Annual report to shareholders
21 Mar 24
DEFA14A
Additional proxy soliciting materials
21 Mar 24
DEF 14A
Definitive proxy
21 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
29 Feb 24
8-K
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
9 Jan 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8 Nov 23
8-K
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
20 Sep 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
2 Aug 23
S-8
Registration of securities for employees
22 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
10 May 23
8-K
Departure of Directors or Certain Officers
5 May 23
ARS
2022 FY
Annual report to shareholders
23 Mar 23
DEFA14A
Additional proxy soliciting materials
23 Mar 23
DEF 14A
Definitive proxy
23 Mar 23
10-K
2022 FY
Annual report
23 Feb 23
8-K
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance
23 Feb 23
8-K
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program
10 Jan 23
8-K
Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults
29 Dec 22
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
Vericel Reports Third Quarter 2022 Financial Results
9 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
8-K
Vericel Reports Second Quarter 2022 Financial Results
3 Aug 22
8-K
Entry into a Material Definitive Agreement
2 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
6 May 22
S-8 POS
Registration of securities for employees (post-effective amendment)
6 May 22
S-8
Registration of securities for employees
6 May 22
10-Q
2022 Q1
Quarterly report
4 May 22
8-K
Vericel Reports First Quarter 2022 Financial Results
4 May 22
8-K
Departure of Directors or Certain Officers
29 Apr 22
DEFA14A
Additional proxy soliciting materials
17 Mar 22
DEF 14A
Definitive proxy
17 Mar 22
8-K
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
24 Feb 22
10-K
2021 FY
Annual report
24 Feb 22
8-K
Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance
24 Feb 22
8-K
Entry into a Material Definitive Agreement
2 Feb 22
Latest ownership filings
4
LISA WRIGHT
3 May 24
4
ROBERT L MD ZERBE
3 May 24
4
Paul K Wotton
3 May 24
4
Heidi Hagen
3 May 24
4
STEVEN C GILMAN
3 May 24
4
KEVIN F MCLAUGHLIN
3 May 24
4
Alan L Rubino
3 May 24
4
Dominick Colangelo
1 May 24
4
Dominick Colangelo
19 Apr 24
144
Notice of proposed sale of securities
18 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
4
Alan L Rubino
11 Apr 24
4
ROBERT L MD ZERBE
29 Mar 24
144
Notice of proposed sale of securities
27 Mar 24
4
Dominick Colangelo
15 Mar 24
4/A
Sean C. Flynn
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
4
Michael Halpin
13 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
JONATHAN SIEGAL
11 Mar 24
4
Sean C. Flynn
11 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
Michael Halpin
26 Feb 24
4
Jonathan Mark Hopper
26 Feb 24
4
Dominick Colangelo
26 Feb 24
4
Sean C. Flynn
26 Feb 24
4
JONATHAN SIEGAL
26 Feb 24
4
Joseph Anthony Mara Jr
26 Feb 24
4
ROBERT L MD ZERBE
22 Feb 24
4
Michael Halpin
22 Feb 24
4
Sean C. Flynn
22 Feb 24
4
Dominick Colangelo
22 Feb 24
4
Joseph Anthony Mara Jr
22 Feb 24
4
JONATHAN SIEGAL
22 Feb 24
4
Jonathan Mark Hopper
22 Feb 24
144
Notice of proposed sale of securities
20 Feb 24
4
Dominick Colangelo
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24